STEMLINE THERAPEUTICS INC - COM (STML)

CUSIP: 85858C107

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
8,438,660
Share change
+98,091
Total reported value
$171,786,274
Price per share
$20.36
Number of holders
57
Value change
+$2,800,896
Number of buys
31
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 85858C107?
CUSIP 85858C107 identifies STML - STEMLINE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of STEMLINE THERAPEUTICS INC - COM (STML) as of Q1 2014

As of 31 Mar 2014, STEMLINE THERAPEUTICS INC - COM (STML) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,438,660 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, TimesSquare Capital Management, LLC, JANUS CAPITAL MANAGEMENT LLC, SAC Capital Advisors LP, EVENTIDE ASSET MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, and BlackRock Fund Advisors. This page lists 57 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.